Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.13)

# 2,930

Out of 5,149 analysts

3

Total ratings

66.67%

Success rate

10.42%

Average return

Main Sectors:

Top Industries:

Health Information Services Drug Manufacturers - Specialty & Generic

Stocks Rated by Matthew Hewitt

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CERT Certara	Initiates: Buy	$16	$7.05	+126.95%	1	Sep 29, 2025
	LFCR Lifecore Biomedical	Maintains: Buy	$8 → $10	$7.23	+38.31%	2	Nov 22, 2024

Certara

Sep 29, 2025

Initiates: Buy

Price Target: $16

Current: $7.05

Upside: +126.95%

Lifecore Biomedical

Nov 22, 2024

Maintains: Buy

Price Target: $8 → $10

Current: $7.23

Upside: +38.31%